Štefan Tóth
3 Papers
3 Citations
Štefan Tóth is an academic researcher. The author has contributed to research in topics: Survival analysis & Internal medicine. The author has an hindex of 2, co-authored 3 publications.
Chat about Author
Papers
Does timeliness of diagnosis influence survival and treatment response in idiopathic pulmonary fibrosis? Real- world results from the EMPIRE registry
Martina Vasakova,Nesrin Mogulkoc,Martina Sterclova,Beata Zolnowska,Vladimir Bartos,Martina Plačková,Veronika Müller,Ladislav Lacina,Robert Slivka,Martina Doubková,Marina Roksandic Milenkovic,Radka Bittenglova,Imrich Jonner,Magdalena Martusewicz-Boros,Monika Žurková,Ilona Binková,Małgorzata Sobiecka,Richard Tyl,Marzena Trzaska-Sobczak,Pawel Sliwinski,Vladimíra Lošťáková,Sebastian Majewski,Pavlína Lisá,Katarzyna Lewandowska,Hana Suldova,Jasna Tekavec-Trkanjec,Amelia Szymanowska-Narloch,Lenka Šišková,Anikó Bohács,Ján Plutinský,Bohumil Matula,Štefan Tóth,František Petřík,Margita Bučeková,Jana Psikalova,Miklós Zsiray,Jaroslav Lněnička,Vladimír Řihák,Zsuzsanna Szalai,Zoltán Balikó,Štefan Laššán,Pavlina Musilova,Imre Lajkó,Tomáš Snížek,Jan Anton,Jiří Homolka,Peter Paluch,Robert Vyšehradský,Renata Králová,Jan Kervitzer,Daniel Doležal,Mária Szilasi,Jan Kus,Dragana Jovanovic,Marta Hájková,Michal Svoboda,Jana Strenková +56 more
TL;DR: The patients with IPF diagnosed within 1 year from symptoms have longer survival than those diagnosed later and treatment with antifibrotic drugs similarly reduced decline of VC and TLCO in both early and later diagnosed patients.
8
Analysis of comorbid conditions in 1210 IPF patients from the EMPIRE registry
D. Jovanovic,Nesrin Mogulkoc,Martina Sterclova,Beata Zolnowska,Vladimir Bartos,Martina Plačková,Veronika Müller,Ladislav Lacina,Robert Slivka,Martina Doubková,Marina Roksandic Milenkovic,Radka Bittenglova,Imrich Jonner,Magdalena Martusewicz-Boros,Monika Žurková,Ilona Binková,Małgorzata Sobiecka,Richard Tyl,Marzena Trzaska-Sobczak,Pawel Sliwinski,Vladimíra Lošťáková,Sebastian Majewski,Pavlína Lisá,Katarzyna Lewandowska,Hana Suldova,Jasna Tekavec-Trkanjec,Amelia Szymanowska-Narloch,Lenka Šišková,Anikó Bohács,Ján Plutinský,Bohumil Matula,Štefan Tóth,František Petřík,Margita Bučeková,Jana Psikalova,Miklós Zsiray,Jaroslav Lněnička,Vladimír Řihák,Zsuzsanna Szalai,Zoltán Balikó,Štefan Laššán,Pavlina Musilova,Imre Lajkó,Tomáš Snížek,Jan Anton,Jiří Homolka,Peter Paluch,Robert Vyšehradský,Renata Králová,Jan Kervitzer,Daniel Doležal,Mária Szilasi,Jan Kus,Marta Hájková,Michal Svoboda,Jana Strenková,Martina Vasakova +56 more
TL;DR: Management of IPF requires a comprehensive approach, which includes the identification and treatment of comorbid conditions to optimize patient outcomes, and the prevalence of COPD, sleep breathing disorder, asthma, nephropathy, hyperlipidaemia, prostatic hypertrophy and depression was strikingly lower than in GP.
3
The European MultiPartner IPF registry (EMPIRE): validating long-term prognostic factors in idiopathic pulmonary fibrosis
T. Tran,T. Tran,Martina Sterclova,Nesrin Mogulkoc,Katarzyna Lewandowska,Veronika Müller,Marta Hájková,Mordechai R. Kramer,D. Jovanovic,Jasna Tekavec-Trkanjec,M.J. Studnicka,Natalia Stoeva,Karel Hejduk,Ladislav Dušek,S. Suissa,S. Suissa,Martina Vasakova,Beata Zolnowska,Vladimir Bartos,Martina Plačková,Robert Slivka,Ladislav Lacina,Martina Doubková,Radka Bittenglova,M. Martusewia-Boros,M. Zurkova,Imrich Jonner,A. Szymanowska-Narioch,Ilona Binková,Małgorzata Sobiecka,V. Lostakova,Marzena Trzaska-Sobczak,Richard Tyl,Pawel Sliwinski,Miklós Zsiray,Pavlína Lisá,Anikó Bohács,Sebastian Majewski,Hana Suldova,Bohumil Matula,Lenka Šišková,J. Plutinsky,A. Jakic,Štefan Tóth,Zoltán Balikó,Margita Bučeková,Jana Psikalova,T. Stachura,F. Petrik,Jan Anton,J. Lnenicka,Marina Roksandic Milenkovic,Imre Lajkó,V. Rihak,Zsuzsanna Szalai,P. Jurek,Aleksander Kania,Štefan Laššán,T. Pejcic,P. Reiterer,L. Borucki,Renata Králová,Pavlina Musilova,T. Snizek,D. Dolezal,Jiří Homolka,H. Hortvikova,S. Mladinov,Peter Paluch,R. Hrdina,Mária Szilasi,V. Vucinic-Mihailovic,R. Vysehradsky,R. Mokosova,A. Nowicka,T. R. Petkovic +75 more
TL;DR: The large European MultiPartner IPF Registry (EMPIRE), one of the largest long-term registries of patients with IPF, provides a more accurate confirmation of prognostic factors and co-morbidities on longer term five-year mortality and suggests that some fine-tuning of the indices for mortality may provide aMore accurate long- term prognostic profile for these patients.